IT1399130B1 - INDULIC DERIVATIVES AND THEIR USE IN MEDICAL FIELD. - Google Patents

INDULIC DERIVATIVES AND THEIR USE IN MEDICAL FIELD.

Info

Publication number
IT1399130B1
IT1399130B1 ITRM2010A000151A ITRM20100151A IT1399130B1 IT 1399130 B1 IT1399130 B1 IT 1399130B1 IT RM2010A000151 A ITRM2010A000151 A IT RM2010A000151A IT RM20100151 A ITRM20100151 A IT RM20100151A IT 1399130 B1 IT1399130 B1 IT 1399130B1
Authority
IT
Italy
Prior art keywords
indulic
derivatives
medical field
medical
field
Prior art date
Application number
ITRM2010A000151A
Other languages
Italian (it)
Inventor
Ettore Novellino
Patrizia Lavia
Andrea Brancale
Romano Silvestri
Ernest Hamel
Regina Giuseppe La
Original Assignee
Consiglio Nazionale Ricerche
Università Degli Studi Di Roma La Sapienza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche, Università Degli Studi Di Roma La Sapienza filed Critical Consiglio Nazionale Ricerche
Priority to ITRM2010A000151A priority Critical patent/IT1399130B1/en
Priority to PCT/IT2011/000099 priority patent/WO2011121629A1/en
Publication of ITRM20100151A1 publication Critical patent/ITRM20100151A1/en
Application granted granted Critical
Publication of IT1399130B1 publication Critical patent/IT1399130B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITRM2010A000151A 2010-04-01 2010-04-01 INDULIC DERIVATIVES AND THEIR USE IN MEDICAL FIELD. IT1399130B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITRM2010A000151A IT1399130B1 (en) 2010-04-01 2010-04-01 INDULIC DERIVATIVES AND THEIR USE IN MEDICAL FIELD.
PCT/IT2011/000099 WO2011121629A1 (en) 2010-04-01 2011-04-01 Indolic derivatives and use thereof in medical field

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2010A000151A IT1399130B1 (en) 2010-04-01 2010-04-01 INDULIC DERIVATIVES AND THEIR USE IN MEDICAL FIELD.

Publications (2)

Publication Number Publication Date
ITRM20100151A1 ITRM20100151A1 (en) 2011-10-02
IT1399130B1 true IT1399130B1 (en) 2013-04-05

Family

ID=42711978

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2010A000151A IT1399130B1 (en) 2010-04-01 2010-04-01 INDULIC DERIVATIVES AND THEIR USE IN MEDICAL FIELD.

Country Status (2)

Country Link
IT (1) IT1399130B1 (en)
WO (1) WO2011121629A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102976986B (en) * 2012-11-20 2014-12-10 溧阳市生产力促进中心 Method for manufacturing polymer used as electron transfer layer of solar cell
CN102993068B (en) * 2012-11-20 2015-01-07 溧阳市生产力促进中心 Electronic transmission layer polymer for solar cell
CN103030581B (en) * 2012-11-20 2015-02-25 溧阳市生产力促进中心 Method for manufacturing electron transfer layer in solar cell
CN108586311B (en) * 2018-03-23 2020-05-26 温州医科大学 Preparation method of 3-thioether indole or 3-seleno-ether indole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099139A1 (en) * 2000-09-15 2004-11-18 Baylor University Indole-containing compounds with anti-tubulin and vascular targeting activity
WO2001019794A2 (en) * 1999-09-17 2001-03-22 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
WO2006041961A1 (en) 2004-10-05 2006-04-20 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTHAND HUMAN SERVICES Arylthioindole tubulin polymerization inhibitors and methods of treating or preventing cancer using same
NZ556686A (en) * 2005-02-14 2010-01-29 Bionomics Ltd Novel tubulin polymerisation inhibitors

Also Published As

Publication number Publication date
ITRM20100151A1 (en) 2011-10-02
WO2011121629A1 (en) 2011-10-06

Similar Documents

Publication Publication Date Title
SMT201600258B (en) INDULIC COMPOUND AND ITS PHARMACEUTICAL USE
SMT201600430B (en) CHINASE INHIBITORS AND THEIR USE IN CANCER TREATMENT
BR112012013148A2 (en) pharmaceutical formulation and use
DK2894151T3 (en) IMIDAZOLINE DERIVATIVES, MANUFACTURING METHODS AND USE IN MEDICINE
IT1403847B1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA AND THEIR USE.
DK3339426T3 (en) USE OF PHOSPHOKETOLASE IN THE MANUFACTURE OF MEVALONATE, ISOPRENOID STARTING MATERIALS AND ISOPREN
BR112012022879A2 (en) compound, pharmaceutical composition, compound use and treatment method
BR112013010988A2 (en) fluid composition and use
BR112012031194A2 (en) cysteamine derivatives and their use in the treatment of ehna
BR112013015592A2 (en) bicyclo- [3.2.1] -octylamide derivatives and their uses
BR112014014763A2 (en) new antibody-drug conjugates (adcs) and their use
BR112012031232A2 (en) method, device and use
BRPI1008045A2 (en) aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
BR112012031226A2 (en) compound, compound use, pharmaceutical composition, and pharmaceutical composition use
BR112013011448A2 (en) compound, pharmaceutical composition, and use of compound
CO7000778A2 (en) Pyrazolopyridine derivatives, their preparation procedure and therapeutic use
CO6890098A2 (en) Pyrazole compound and its pharmaceutical use
BR112012031492A2 (en) interventional surgical field and kit for interventional procedures
CO6781486A2 (en) Compounds and their use
BRPI1014295A2 (en) composition and its use, co-framed film and article
DK2938186T3 (en) ORGANIC AND TISSUE STORAGE FORMULATIONS WITH INCREASED STABILITY AND STABILITY
IT1399793B1 (en) PROCEDURE FOR THE PREPARATION OF A BIOMASS INCLUDING PLANTARICINA AND ITS USES IN MEDICAL FIELD.
FI20106220A (en) Procedure and arrangement in connection with wheelchair operation
BR112013023575A2 (en) “octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof”
BRPI1009067A2 (en) nitrile derivatives, their pharmaceutical use and compositions